Dextroamphetamine - Amphetamine ER Solicitation
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D2-25-R-0013
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is soliciting proposals for Dextroamphetamine-Amphetamine Extended Release (ER) capsules across six dosage strengths (5mg, 10mg, 15mg, 20mg, 25mg, and 30mg) in 100-count bottles. This pharmaceutical procurement will establish a national supply contract to serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through pharmaceutical prime vendor distribution channels. Offerors must demonstrate FDA approval, current Good Manufacturing Practices compliance, therapeutic equivalence, and the capability to provide uninterrupted supply through prime vendor networks. The solicitation follows a lowest price technically acceptable (LPTA) evaluation methodology, requiring comprehensive proposals submitted through the Defense Logistics Agency Internet Bid Board System. The proposal deadline has been extended twice through amendments, with the final submission deadline set for June 27, 2025, at 3:00 PM EDT.
This procurement does not utilize any set-aside designations and is open to all eligible pharmaceutical manufacturers meeting the technical requirements. The contract structure includes a one-year base period with four option years, creating a potential maximum contract term of five years. Estimated annual quantities range from 7,915 to 46,119 bottles depending on the specific dosage strength, with Amendment 0002 correcting the quantity for one line item to 12,094 bottles for the base and all option years. The solicitation references FAR 52.216-21 Requirements, indicating flexibility in actual order volumes from the estimated quantities. Performance will be executed through the existing pharmaceutical prime vendor distribution network, serving federal agencies nationwide through established medical supply chain infrastructure.
Notice text
Solicitation and amendments 001 and 002 attached.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Dextroamphetamine - Amphetamine ER - Contract Award | Award Notice | |
| This notice | Solicitation | |
| Dextroamphetamine - Amphetamine ER Solicitation | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity